News

Published on 25 Jan 2023 on Digital Journal

Opioid Market Size, Growth, Segments, Revenue, Manufacturers and 2032 Forecast


Article preview image

The report provides a massive information concerning the outstanding, first-time present and...

NSE.SUNPHARMA price evolution
NYSE.AMRX price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Generic Drug Maker Amneal Pharmaceuticals Is Positioned To Growth Well Ahead Of...

J.P. Morgan has upgraded Amneal Pharmaceuticals, Inc (NASDAQ:AMRX), noting the company’s generics...

Benzinga · via Yahoo Finance 24 Feb 2025

Although Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) insiders have sold lately,...

Key Insights Amneal Pharmaceuticals' significant insider ownership suggests inherent interests in...

Simply Wall St. · via Yahoo Finance 13 Feb 2025

Here’s Why Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Is Among the Best Diabetes...

We recently compiled a list of the 10 Best Diabetes Stocks To Buy Under $10. In this article, we ...

Insider Monkey · via Yahoo Finance 6 Jan 2025

Amneal Pharmaceuticals Inc (AMRX) Q3 2024 Earnings Call Highlights: Strong...

Release Date: November 08, 2024 For the complete transcript of the earnings call, please refer to...

GuruFocus.com · via Yahoo Finance 10 Nov 2024

Generic Drug-Focused Amneal Beats Q3 Expectations, Reaffirms Annual Forecasts

On Friday, Amneal Pharmaceuticals Inc (NASDAQ:AMRX) reported third-quarter adjusted EPS of $0.16,...

Benzinga · via Yahoo Finance 8 Nov 2024

Earnings To Watch: Amneal Pharmaceuticals Inc (AMRX) Reports Q3 2024 Result

Amneal Pharmaceuticals Inc (NASDAQ:AMRX) is set to release its Q3 2024 earnings on Nov 8, 2024. T...

GuruFocus.com · via Yahoo Finance 7 Nov 2024

Amneal Pharmaceuticals Inc (AMRX) Q2 2024 Earnings Call Highlights: Strong...

Q2 Revenue: $702 million, a growth of 17%. Generics Net Revenue: $427 million, up 14%. Biosimilar...

GuruFocus.com · via Yahoo Finance 11 Oct 2024

Insider Sale at Amneal Pharmaceuticals Inc (AMRX): Executive Vice President...

The transaction was documented in a recent SEC Filing. Following this sale, the insider now owns...

GuruFocus.com · via Yahoo Finance 24 Aug 2024

Insider Sale at Amneal Pharmaceuticals Inc (AMRX) by Executive Vice President...

Following this transaction, the insider now owns 256,670 shares of Amneal Pharmaceuticals Inc....

GuruFocus.com · via Yahoo Finance 8 Aug 2024

Insider Sale: Director Deborah Autor Sells 38,000 Shares of Amneal Pharmaceuticals Inc (AMRX)

On May 17, 2024, Deborah Autor, Director at Amneal Pharmaceuticals Inc (NASDAQ:AMRX), executed a ...

GuruFocus.com via Yahoo Finance 22 May 2024